Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation

Recruiting N/A Interventional Study
Fecal Microbiota Transplantation Cesarean Section Overweight and Obesity
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
0 Hours – 6 Hours
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
460 (estimated)
Sponsor
Oulu University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This single-center randomized controlled trial evaluates whether donor-derived fecal microbiota transplantation (FMT) administered within 6 hours after birth can improve gut microbiota development and reduce the risk of immune-mediated and metabolic diseases in infants born by elective cesarean delivery. Newborns are randomized 1:1 to receive either donor-derived FMT or standard postnatal care. Pa…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Pregnant women aged 18 to 49 years Scheduled for elective cesarean delivery at term (≥37 completed weeks of gestation) Willing and able to provide written informed consent Infant eligible for study participation following birth Exclusion Criteria (Mother): Age \<18 years or \>…
Contacts

Marika Paalanne, MD, PhD

+358505794646

marika.paalanne@oulu.fi

CONTACT

Terhi Ruuska-Loewald, Professor

+358505794420

terhi.ruuska-loewald@oulu.fi

CONTACT